NEW YORK, NY--(Marketwired - January 07, 2015) - Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 7:30 a.m. PT at the Westin St. Francis in San Francisco, CA. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs.
About Kadmon Corporation
Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, autoimmune and fibrotic diseases, monogenic diseases and metabolic disease. For more information, visit www.kadmon.com.
This press release contains forward-looking statements. These forward-looking statements are based on management’s expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
Contact Information
Ellen Tremaine
Investors
646.490.2989
Email Contact
David Pitts
Argot Partners
212.600.1902
Email Contact
Help employers find you! Check out all the jobs and post your resume.
